Literature DB >> 11191051

Tek/Tie2 signaling: new and old partners.

N Jones1, D J Dumont.   

Abstract

A common property amongst angiogenic ligands such as the vascular endothelial growth factors and the angiopoietins is that they can elicit multiple responses depending upon the context of their expression and the presence of other growth factors. Study of the signal transduction pathways initiated by these growth factors provides insight into the molecular and cellular mechanisms that regulate vessel assembly. Key components of signal transduction cascades can then be used as potential targets in angiogenic therapies. This commentary reviews the recent advances into understanding the molecular signaling pathways mediated through the angiopoietin receptor, Tek/Tie2, as well as their effect on the regulation of distinct cellular aspects of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191051     DOI: 10.1023/a:1026555121511

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  13 in total

1.  Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling.

Authors:  Peter J Mack; Yuzhi Zhang; Seok Chung; Vernella Vickerman; Roger D Kamm; Guillermo García-Cardeña
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

2.  Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.

Authors:  Y Yu; J Varughese; L F Brown; J B Mulliken; J Bischoff
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther M John; Gabriela Torres-Mejia; Abbie Lundgreen; Juan Pablo Lewinger; Mariana C Stern; Lisa Hines; Kathy B Baumgartner; Anna R Giuliano; Roger K Wolff
Journal:  Int J Cancer       Date:  2013-08-09       Impact factor: 7.396

Review 4.  Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.

Authors:  A A Timur; D J Driscoll; Q Wang
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

5.  Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1.

Authors:  Gelareh Zadeh; Rob Reti; Keyvan Koushan; Qian Baoping; Patrick Shannon; Abhijit Guha
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

6.  Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.

Authors:  Christopher C Sullivan; Lingling Du; Danny Chu; Augustine J Cho; Masakuni Kido; Paul L Wolf; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

7.  Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development.

Authors:  Jacinthe Sirois; Jean-François Côté; Alain Charest; Noriko Uetani; Annie Bourdeau; Stephen A Duncan; Eugene Daniels; Michel L Tremblay
Journal:  Mech Dev       Date:  2006-09-01       Impact factor: 1.882

8.  Minimally perturbing a gene regulatory network to avoid a disease phenotype: the glioma network as a test case.

Authors:  Guy Karlebach; Ron Shamir
Journal:  BMC Syst Biol       Date:  2010-02-25

9.  Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.

Authors:  Adrian Mehlitz; Sebastian Banhart; André P Mäurer; Alexis Kaushansky; Andrew G Gordus; Julia Zielecki; Gavin Macbeath; Thomas F Meyer
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

10.  Molecular profiling of angiogenesis markers.

Authors:  Shu-Ching Shih; Gregory S Robinson; Carole A Perruzzi; Alfonso Calvo; Kartiki Desai; Jeffery E Green; Iqbal U Ali; Lois E H Smith; Donald R Senger
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.